ロード中...
rhIGF-1 Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia (PMM2 Deficiency)
Background. Congenital disorders of glycosylation (CDG) are a group of rare disorders in which glycosylation required for proper protein-protein interactions and protein stability is disrupted, manifesting clinically with multiple system involvement and growth failure. The insulin-like growth factor...
保存先:
| 出版年: | J Investig Med High Impact Case Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4586814/ https://ncbi.nlm.nih.gov/pubmed/26425584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709613503316 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|